Skip to content

Safety and Efficacy of LOw Volum bowel preparation for Elderly

Safety, Efficacy and Tolerability of LOw Volum bowel preparation for Elderly; prospective randomized single-blinded trial

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
CRIS
Registry ID
KCT0004224
Enrollment
106
Registered
2019-08-21
Start date
2019-09-04
Completion date
Unknown
Last updated
2020-02-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

Drug : *Both solution already come into the market for bowel preparation before colnoscopic examination - Gorup 1/ 1L PEG/Asc(Clean View All) / Split dose i) At 8 pm on the day befor the exam, drin

Sponsors

Yeongnam University Medical Center
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: ? Subjects same or older than 65 years who undergo diagnostic colonoscopy ? Subjects who signed to informed consent

Exclusion criteria

Exclusion criteria: ? Younger than 65 years ? intestinal obstruction ? severe constipation (lesser than 3 per week, take laxative)?? ??? ???? ? ? History of coloectomy ? History of liver cirrhosis, ascotes, chronic kidney disease, inflammtory bowel disease, significant other inflammatory disease ? Congestive heart failure, other heart disease(ischemic heart disease within recent 6 months, coronary artery disease) ? subjects with decreased renal function ( serum creatinine > 3 mg/dl for more than 5 months) ? glucose 6 phosphate dehydrogenase deficiency ? disabled (cognitive impairment, low inteligence) ? subjects who refused to sign to informed consent ? Higher than American Society of Anesthesiology class III

Design outcomes

Primary

MeasureTime frame
adequate bowel preparation(Boston Bowel preparation Scale = 6;adenoma and advanced adenoma detection rate;colonoscopy withdrawal time;serum electrolyte and kidney function;adverse event during drinking preparation solution( safety- nausea, vomiting, abdominal pain, abdominal distension, insomnia, numbness, leghargy, tremor, decreased mentality, fecal incontinence, nephrotoxicity);erythematous mucosal change or aphthous ulcer;flare up of IBD after colonoscopy

Secondary

MeasureTime frame
tolerability;adherenc;satisfaction

Countries

Korea, Republic of

Contacts

Public ContactHALIN KWON

Yeongnam University Medical Center

Outcome results

None listed

Source: CRIS (via WHO ICTRP) · Data processed: Feb 4, 2026